Primary cutaneous CD30-positive anaplastic large cell lymphoma in a 16-year-old girl

International Journal of Dermatology

Volumn 51, Issue 11, 2012, Pages 1353-1358

  Kocabaş, Engin ^a   Türel Ermertcan, Aylin ^a   Akinci, Sibel ^b   Temiz, Peyker ^a   Gündüz, Kamer ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Merkez Efendi State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LEUKOCYTOCLASTIC VASCULITIS; PYODERMA GANGRENOSUM; SKIN BIOPSY;

ADOLESCENT; ANTIGENS, CD30; FEMALE; HUMANS; LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL;

EID: 84867688159     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05157.x     Document Type: Article

References (14)

1. Kadin ME. Current management of primary cutaneous CD30+ Tcell lymphoproliferative disorders. Oncology 2009; 23: 1158-1164.
2. Bekkenk W, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30 (+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653-3661.
3. Querfeld C, Khan I, Mahon B, et al. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Oncology 2010; 24: 574-587.
4. Assaf C, Sterry W. Skin manifestations of bone marrow and blood disorders. In: Wolff K, Goldsmith L, Katz SI, et al., eds. Fitzpatrick's Dermatology in General Medicine, 7th edn. New York, NY: McGraw Hill, 2008; 1373-1445.
5. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38: 877-898.
6. Meier F, Schaumburg-Lever G, Kaiserling E, et al. Primary cutaneous large-cell anaplastic (Ki-1) lymphoma in a child. J Am Acad Dermatol 1992; 26: 813-817.
7. Tomaszewski MM, Moad JC, Lupton GP. Primary cutaneous Ki-1 (CD30) positive anaplastic large cell lymphoma in childhood. J Am Acad Dermatol 1999; 40: 857-861.
8. Gould JW, Eppes RB, Gilliam AC, et al. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5) (p23; q35) translocation and presenting in a child. Am J Dermatopathol 2000; 22: 422-428.
9. Hinshaw M, Trowers AB, Kodish E, et al. Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5) (p23; q35) translocation. Pediatr Dermatol 2004; 21: 212-217.
10. Kumar S, Pittaluga S, Raffeld M, et al. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of four cases and review of the literature. Pediatr Dev Pathol 2005; 8: 52-60.
11. Hung TY, Lin YC, Sun HL, Liu MC. Primary cutaneous anaplastic large cell lymphoma in a young child. Eur J Pediatr 2008; 167: 111-113.
12. Santiago-et-Sánchez-Mateos D, Hernández-Martín A, Colmenero I, et al. Primary cutaneous anaplastic large cell lymphoma of the nasal tip in a child. Pediatr Dermatol 2010; doi: 10.1111/j.1525-1470.2010.01245.x; Epub ahead of print.
13. Slater DN. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol 2005; 53: 874-880.
14. Shehan JM, Kalaaji AN, Markovic SN, Ahmed I. Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma. J Am Acad Dermatol 2004; 51: 103-110.